NCT06162455View on ClinicalTrials.gov

High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

January 15, 2024

Study Completion Date

February 6, 2024

Conditions
Nosocomial Pneumonia
Interventions
DRUG

Sham treatment

Oxygen-air mixture without NO after extubation after surgery for 5 days 2 times a day for 30 min

DRUG

200- ppm NO

NO will be supplemented at 200-ppm concentration after surgery for 5 days 2 times a day for 30 min

Trial Locations (1)

634012

Cardiology Research Institute Tomsk National Research Medical Center, Tomsk

All Listed Sponsors
lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER

NCT06162455 - High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB | Biotech Hunter | Biotech Hunter